MORESCO, ROSA MARIA
 Distribuzione geografica
Continente #
NA - Nord America 26.739
EU - Europa 14.304
AS - Asia 12.136
SA - Sud America 1.703
Continente sconosciuto - Info sul continente non disponibili 924
AF - Africa 263
OC - Oceania 31
Totale 56.100
Nazione #
US - Stati Uniti d'America 25.284
SE - Svezia 4.855
SG - Singapore 3.884
IT - Italia 2.931
CN - Cina 2.499
VN - Vietnam 2.272
DE - Germania 1.654
HK - Hong Kong 1.446
RU - Federazione Russa 1.322
BR - Brasile 1.292
CA - Canada 1.138
IE - Irlanda 774
GB - Regno Unito 595
UA - Ucraina 570
BD - Bangladesh 406
FR - Francia 387
IN - India 332
FI - Finlandia 302
KR - Corea 220
AT - Austria 189
TR - Turchia 154
ID - Indonesia 150
AR - Argentina 137
NL - Olanda 129
PL - Polonia 116
IQ - Iraq 113
ES - Italia 111
JP - Giappone 97
ZA - Sudafrica 83
SA - Arabia Saudita 82
DK - Danimarca 81
PK - Pakistan 77
MX - Messico 75
CH - Svizzera 67
EC - Ecuador 63
PH - Filippine 62
CO - Colombia 60
BE - Belgio 44
VE - Venezuela 44
JM - Giamaica 43
UZ - Uzbekistan 40
MA - Marocco 37
CR - Costa Rica 36
CL - Cile 30
IR - Iran 29
EG - Egitto 28
KE - Kenya 28
AE - Emirati Arabi Uniti 27
SV - El Salvador 27
LT - Lituania 26
PY - Paraguay 26
MY - Malesia 25
AU - Australia 24
IL - Israele 24
HN - Honduras 23
CZ - Repubblica Ceca 21
TH - Thailandia 21
TN - Tunisia 20
ET - Etiopia 18
TT - Trinidad e Tobago 18
BO - Bolivia 17
DZ - Algeria 17
GT - Guatemala 17
NI - Nicaragua 17
NP - Nepal 17
PT - Portogallo 17
UY - Uruguay 17
KZ - Kazakistan 16
RO - Romania 16
OM - Oman 15
BG - Bulgaria 14
LB - Libano 14
TW - Taiwan 14
JO - Giordania 13
KG - Kirghizistan 13
PR - Porto Rico 13
EE - Estonia 11
PA - Panama 11
AZ - Azerbaigian 10
CW - ???statistics.table.value.countryCode.CW??? 10
GP - Guadalupe 10
BH - Bahrain 9
GR - Grecia 9
PE - Perù 9
PS - Palestinian Territory 9
AL - Albania 8
DO - Repubblica Dominicana 8
HU - Ungheria 8
NZ - Nuova Zelanda 7
SR - Suriname 7
AM - Armenia 6
MD - Moldavia 6
RS - Serbia 6
BB - Barbados 5
EU - Europa 5
GE - Georgia 5
KW - Kuwait 5
LV - Lettonia 5
MK - Macedonia 5
SY - Repubblica araba siriana 5
Totale 55.094
Città #
Stockholm 3.718
Ann Arbor 3.335
Ashburn 2.864
Singapore 2.368
Hong Kong 1.402
Fairfield 1.401
San Jose 1.400
Woodbridge 1.299
Houston 1.073
Milan 891
Chandler 863
Frankfurt am Main 765
Wilmington 764
Toronto 760
Dublin 744
Council Bluffs 728
Ho Chi Minh City 652
Jacksonville 592
New York 589
Seattle 543
Santa Clara 534
Hanoi 529
Dearborn 476
Cambridge 406
Dallas 402
Los Angeles 392
Chicago 357
Beijing 351
Hefei 345
Princeton 297
The Dalles 256
Nanjing 208
Rome 208
Munich 204
Seoul 202
Lauterbourg 152
Lawrence 141
Vienna 140
Columbus 139
Buffalo 137
Shanghai 135
Altamura 132
São Paulo 130
Boardman 128
Helsinki 126
Moscow 115
Jakarta 105
San Diego 104
Lachine 96
Orem 92
Dong Ket 91
Montreal 84
Haiphong 83
London 79
Phoenix 79
Tokyo 79
Da Nang 78
Washington 78
Guangzhou 69
Brooklyn 67
Denver 61
Shenyang 61
Warsaw 60
Atlanta 56
North Kansas City 51
Naples 50
Turin 50
Nanchang 49
Tianjin 49
Biên Hòa 47
Fremont 46
Jinan 46
Nuremberg 46
Figino 43
Andover 41
Miami 41
Amsterdam 40
Baghdad 40
Changsha 40
Zurich 40
Brussels 39
Hải Dương 39
Salt Lake City 38
Johannesburg 37
Manchester 36
Nürnberg 36
Turku 36
Bologna 35
Dhaka 35
Kraków 35
Chennai 34
Falls Church 34
Hebei 34
Philadelphia 34
Tashkent 34
Boston 33
Hangzhou 33
Monza 33
Rio de Janeiro 33
Charlotte 32
Totale 36.234
Nome #
Micro and nano plastics are everywhere: impact on intestinal inflammation and brain health 2.003
Effects of microplastics and nanoplastics on intestine inflammation 1.979
Radio-chemotherapy and metformin selectively modulate the heterogeneous landscape of glioma with ribosome biogenesis, long non coding RNA and immune-escape markers as major player 850
Inhibition of the Hexosamine Biosynthetic Pathway by targeting PGM3 causes breast cancer growth arrest and apoptosis 727
Automated radiosynthesis and preclinical evaluation of two new PSMA-617 derivatives radiolabelled via [18F]AlF2+ method 614
99mTc-radiolabeled silica nanocarriers for targeted detection and treatment of HER2-positive breast cancer 583
Development of99mtc-radiolabeled nanosilica for targeted detection of HER2-positive breast cancer 579
Study of the tissue distribution of TLQP-21 in mice using [18F]JMV5763, a radiolabeled Analog prepared via [18F]aluminum fluoride chelation chemistry 566
Synthesis, labeling, and biological evaluation of halogenated 2-quinolinecarboxamides as potential radioligands for the visualization of peripheral benzodiazepine receptors 558
Divergent in vitro/in vivo responses to drug treatments of highly aggressive NIH-Ras cancer cells: A PET imaging and metabolomics-mass-spectrometry study 553
11C-Labelling of N-[4-[4-(2,3-Dichlorophenyl)piperazin-1-yl]butyl]arylcarboxamide Derivatives and Evaluation as Potential Radioligands for PET imaging of Dopamine D3 Receptors 493
In vivo imaging of adenosine A2A receptors in rat and primate brain using [11C]SCH442416 480
Evaluation of three quinoline-carboxamide derivatives as potential radioligands for the in vivo pet imaging of neurodegeneration 475
Metformin and temozolomide, a synergic option to overcome resistance in glioblastoma multiforme models 463
Acute Inescapable Stress Rapidly Increases Synaptic Energy Metabolism in Prefrontal Cortex and Alters Working Memory Performance 458
Radiosynthesis and Preclinical Evaluation of 11C-VA426, a Cyclooxygenase-2 Selective Ligand 455
Disruption of redox homeostasis for combinatorial drug efficacy in K-Ras tumors as revealed by metabolic connectivity profiling 448
11C-radiosynthesis and preliminary human evaluation of the disposition of the ACE inhibitor [11C]Zofenoprilat 439
From cancer metabolism to new biomarkers and drug targets 425
Translation Imaging in Parkinson’s Disease: Focus on Neuroinflammation 424
18 F-VC701-PET and MRI in the in vivo neuroinflammation assessment of a mouse model of multiple sclerosis 423
Imaging Metformin Efficacy as Add-On Therapy in Cells and Mouse Models of Human EGFR Glioblastoma 409
PET imaging and single-cell RNA sequencing glioma microenvironment assessment after RT combined therapy 404
Evaluating [18F]FDG and [18F]FLT Radiotracers as Biomarkers of Response for Combined Therapy Outcome in Triple-Negative and Estrogen-Receptor-Positive Breast Cancer Models 385
Givinostat-Liposomes: Anti-Tumor Effect on 2D and 3D Glioblastoma Models and Pharmacokinetics 383
Time course of metabolic activity and cellular infiltration in a murine model of acid-induced lung injury 378
A novel AMPK activator reduces glucose uptake and inhibits tumor progression in a mouse xenograft model of colorectal cancer 377
Characterization of biological features of a rat F98 GBM model: a PET-MRI study with [18F]FAZA and [18F]FDG 375
Preliminary assessment of semiautomated segmentation tool for GBM neurosurgery: a BraTS-Toolkit approach 373
Cancer cell growth and survival as a system-level property sustained by enhanced glycolysis and mitochondrial metabolic remodeling 371
Age and Sex Influence the Neuro-inflammatory Response to a Peripheral Acute LPS Challenge 368
A systems biology road map for the discovery of drugs targeting cancer cell metabolism 362
Clinical applicability of pCASL as a substitute for FDG-PET in the etiological diagnosis of MCI and SCD: CAPE study protocol 361
An optimized protocol for correlation of PET-FDG and pCASL data in mild cognitive impairment (MCI) patients 360
Role of metformin and AKT axis modulation in the reversion of hypoxia induced TMZ-resistance in glioma cells 357
Synthesis and in vivo evaluation of 3-[C-11]methyl-(3-methoxy-naphthalen)-2-yl-(1-benzyl-piperidin)-4-yl-acetate (SB-235753), as a putative dopamine D-4 receptors antagonist for PET 354
Identification of imaging biomarkers for the assessment of tumour response to different treatments in a preclinical glioma model 353
Stem Cell-Derived Human Striatal Progenitors Innervate Striatal Targets and Alleviate Sensorimotor Deficit in a Rat Model of Huntington Disease 349
Imaging temozolomide-induced changes in the myeloid glioma microenvironment 347
Monitoring disease evolution and treatment response in lysosomal disorders by the peripheral benzodiazepine receptor ligand PK11195 345
The p53-p66Shc apoptotic pathway is dispensable for tumor suppression whereas the p66Shc-generated oxidative stress initiates tumorigenesis 345
Evaluation of the role of tumor-associated macrophages in an experimental model of peritoneal carcinomatosis using 18F-FDG PET 343
Quinolinic acid induced neurodegeneration in the striatum: a combined in vivo and in vitro analysis of receptor changes and microglia activation 339
Validation of an Engineered Cell Model for In Vitro and In Vivo HIF-1α Evaluation by Different Imaging Modalities 336
Characterization of preclinical models of prostate cancer using PET-based molecular imaging 334
Metabolic evaluation of non-small cell lung cancer patient-derived xenograft models using 18F-FDG PET: A potential tool for early therapy response 332
[11C]RN5: A new agent for the in vivo imaging of myocardial α1-adrenoceptors 331
Tumour hypoxia: lessons learnt from preclinical imaging 327
Comparison of 18F-fluoroazomycin-arabinofuranoside and 64Cu-diacetyl-bis(N4-methylthiosemicarbazone) in preclinical models of cancer 322
Basal ganglia and language: Phonology modulates dopaminergic release 320
Ibuprofen plus isosorbide dinitrate treatment in the mdx mice ameliorates dystrophic heart structure 319
Leukocytes recruited by tumor-derived HMGB1 sustain peritoneal carcinomatosis 316
Sperimentazione clinica con radiofarmaci 315
3D Spatial resolution proprieties of Molecubes β-Cube: Characterization with different isotopes 313
Brain sex-dependent alterations after prolonged high fat diet exposure in mice 308
A Decision Support System for the assisted diagnosis of brain tumors: a feasibility study for ¹⁸F-FDG PET preclinical studies 308
VEGF-targeted therapy stably modulates the glycolytic phenotype of tumor cells 305
Validation of brain 18FDG-PET and pCASL joint analysis tool: a ROI-based approach 305
Early upregulation of 18-kDa translocator protein in response to acute neurodegenerative damage in TREM2-deficient mice 304
The peritumoral brain zone in glioblastoma: where we are and where we are going 301
Synthesis and carbon-11 labeling of (R)- and (S)-Thionisoxetine, norepinephrine reuptake inhibitors, potential radioligands for Positron Emission Tomography 300
Modulazione del fenotipo cellulare indotto da radioterapia ipofrazionata in un modello murino di glioma 300
Synthesis and in vivo evaluation of [11C]ICI 118551 as a putative subtype selective β2-adrenergic radioligand 299
Cholinergic activity correlates with reserve proxies in Alzheimer's disease 297
[11]-MP4A PET cholinergic measurements in amnestic mild cognitive impairment, probable Alzheimer's disease, and dementia with lewy bodies: A Bayesian method and voxel-based analysis 296
The driving role of the Cdk5/Tln1/FAKS732 axis in cancer cell extravasation dissected by human vascularized microfluidic models 292
A voxel-based PET study of dopamine transporters in Parkinson's disease: relevance of age at onset 291
Acute stress studies in rats by 18 FDG PET and SPM 289
A ROI-based quantitative pipeline for 18F-FDG PET metabolism and pCASL perfusion joint analysis: Validation of the 18F-FDG PET line 287
Therapeutic antibody targeting of Notch1 in T-acute lymphoblastic leukemia xenografts 287
Regional Differences in Cerebral Glucose Metabolism After Cardiac Arrest and Resuscitation in Rats Using [18F]FDG Positron Emission Tomography and Autoradiography 287
Asymmetric synthesis and preliminary evaluation of (R)- and (S)-[11C]bisoprolol, a putative beta1-selective adrenoceptor radioligand 286
Development of a bicistronic vector for multimodality imaging of estrogen receptor activity in a breast cancer model: preliminary application 285
Quantification of Dynamic [18F]FDG Pet Studies in Acute Lung Injury 284
Radiosynthesis of [123I]βCIT, a selective ligand for the study of the dopaminergic and serotoninergic systems in human brain 283
In vivo susceptibility to energy failure parkinsonism and LRRK2 kinase activity 283
Evaluation of [O-methyl-(11)C]fluvoxamine as a tracer for serotonin re-uptake sites 279
Feasibility of supervised machine learning technique for assisted diagnosis of cancer: application to PET studies in small animals 278
[18F]FDG and [18F]FLT PET for the evaluation of response to neo-adjuvant chemotherapy in a model of triple negative breast cancer 277
PET and SPET molecular imaging: Focus on serotonin system 276
Inhibiting glycolysis rescues memory impairment in an intellectual disability Gdi1-null mouse 273
Acute effect of 3-(4-acetamido)-butyrril-lorazepam (dds2700) on brain function assessed by pet at rest and during attentive tasks 272
Labeling and evaluation of N-[11C]methylated quinoline-2-carboxamides as potential radioligands for visualization of peripheral benzodiazepine receptors 268
In vivo serotonin 5HT(2A) receptor binding and personality traits in healthy subjects: a positron emission tomography study 267
Errors introduced by tissue heterogeneity in estimation of local cerebral glucose utilization with current kinetic models of the [18F]fluorodeoxyglucose method 266
Molecular imaging of IDH-mutant gliomas in the new era of IDH inhibitors: preparing for future challenges 265
Exploring the neuroprotective effects of montelukast on brain inflammation and metabolism in a rat model of quinolinic acid-induced striatal neurotoxicity 265
Human malignant mesothelioma is recapitulated in immunocompetent BALB/c mice injected with murine AB cells 265
In vivo PET study of 5HT2A serotonin and D2 dopamine dysfunction in drug-naive obsessive-compulsive disorder 263
Myocardial glucose uptake evaluated by positron emission tomography and fluorodeoxyglucose during hyperglycemic clamp in IDDM patients: Role of free fatty acid and insulin levels 263
GABAa receptor abnormalities in Prader-Willi syndrome assessed with positron emission tomography and [11C]flumazenil 262
Synthesis and Biological Characterization of Novel 2-Quinolinecarboxamide Ligands of the Peripheral Benzodiazepine Receptors Bearing Technetium-99m or Rhenium 262
Systemic and cerebral kinetics of 16α[18F]fluoro-17β-estradiol: A ligand for the in vivo assessment of estrogen receptor binding parameters 262
Synthesis and Biodistribution of (R,S)-[O-Methyl-11C]-1-[3-(5-Methoxy-1,2,3,4-Tetrahydro-1-Naphtalenyl)Propyl]-4-Phenylpiperazine (PNU-157760), A Putative Radioligand for 5-HT1A Receptors 262
Radiosynthesis and preliminary biological evaluation of [18F]VC701, a radioligand for translocator protein 262
An In Vivo 11C-(R)-PK11195 PET and In Vitro Pathology Study of Microglia Activation in Creutzfeldt-Jakob Disease 258
[18f]-(2S,4R)-4-Fluoroglutamine As a New Positron Emission Tomography Tracer in Multiple Myeloma 257
Validation and Performance Assessment of a Preclinical SiPM-Based SPECT/MRI Insert 257
Synthesis and in vivo evaluation of [C-11]CGP62349, a new GABA(B) receptor antagonist 256
Glycine N-Methylation in NGR-Tagged Nanocarriers Prevents Isoaspartate Formation and Integrin Binding without Impairing CD13 Recognition and Tumor Homing 256
Totale 38.446
Categoria #
all - tutte 164.885
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 164.885


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.827 0 0 0 287 168 187 144 148 147 183 191 372
2022/20233.717 453 1.022 338 315 285 531 60 203 271 35 113 91
2023/20242.696 114 100 100 136 333 714 484 90 217 65 44 299
2024/20256.490 383 689 513 272 496 299 450 289 627 936 501 1.035
2025/202621.987 2.427 1.264 1.212 1.867 1.927 944 2.294 861 1.382 5.043 1.355 1.411
2026/20275.224 626 753 1.743 2.102 0 0 0 0 0 0 0 0
Totale 56.100